Skip to content

Methoxamine infusion to prevent hypotension for cesarean delivery

A study for dose-dependent effects of intravenous methoxamine infusion to prevent hypotension for cesarean delivery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018988
Enrollment
Unknown
Registered
2018-10-20
Start date
2018-10-16
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypotension

Interventions

Group M2:methoxamine infusion regimens (2µg/kg/min)
Group M3:methoxamine infusion regimens (3µg/kg/min)
Group M4:methoxamine infusion regimens (4µg/kg/min)
Group M1:methoxamine infusion regimens (1µg/kg/min)

Sponsors

Women's Hospital School of Medicine Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Parturients with a singleton pregnancy scheduled for elective cesarean delivery were enrolled into the study.

Exclusion criteria

Exclusion criteria: Patients were excluded if they had pre-existing or pregnancy-induced hypertension, diabetes mellitus, known cardiovascular or cerebrovascular disease, fetal abnormality, or contraindication to spinal anesthesia. The patients whose American Society of Anesthesiologists physical status (ASA >2), body mass index > 30 kg/m2, height 170 cm, gestational age < 36 weeks were also excluded from the study.

Design outcomes

Primary

MeasureTime frame
Blood pressure;

Countries

China

Contacts

Public ContactXinzhong Chen

Women's Hospital School of Medicine Zhejiang University

chenxinz@zju.edu.cn+86 13575738058

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 26, 2026